Yulia S. Chistyachenko, Elizaveta S. Meteleva, Maria Y. Pakharukova, Aleksey V. Katokhin, Mikhail V. Khvostov, Anastasiya I. Varlamova, Igor I. Glamazdin, Salavat S. Khalikov, Nikolay E. Polyakov, Ivan A. Arkhipov, Tatyana G. Tolstikova, Viatcheslav A. Mordvinov, Alexander V. Dushkin and Nikolay Z. Lyakhov
Cleonice Marques Costa, Leticia Coli Louvisse de Abreu, Elisabete Pereira dos Santos, Octavio Augusto Franca Presgrave, Anna Paola Trindade Rocha Pierucci, Carlos Rangel Rodrigues, Valeria Pereira de Sousa, Sara Nicoli, Eduardo Ricci Junior and Lucio Mendes Cabral
Marina Yurinskaya, Olga G. Zatsepina, Maxim G. Vinokurov, Natalia V. Bobkova, David G. Garbuz, Alexei V. Morozov, Dina A. Kulikova, Vladimir A. Mitkevich, Alexander A. Makarov, Sergei Yu. Funikov and Michael B. Evgen’ev
Dr. Xing-Jie Liang got his Ph.D at National Key Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing. Dr. Liang also holds a postdoc with Dr. Michael M. Gottesman (Deputy Director of NIH, USA) for 5 years at Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Currently Dr. Liang is deputy director of Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Chinese Academy of Sciences and Lab Chief of Laboratory of Controllable Nanopharmaceuticals, National Center for Nanoscience and Technology of China. He has published more than 80 scientific publications..